Summaries from the Eleventh Annual Houston Conference on AIDS in America.
D016915:AIDS Vaccines; D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D000329:Advertising; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000821:virology; D004347:Drug Interactions; D015507:Drugs, Investigational; D004989:Ethics; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000635:transmission; D015497:HIV-1; D006297:Health Services Accessibility; D006801:Humans; D007167:Immunotherapy; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D013781:Texas; D017735:Virus Latency; D014779:Virus Replication
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D016178:Granulocyte-Macrophage Colony-Stimulating Factor